Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ataluren and Similar Compounds (specific Therapies for Premature Termination Codon Class I Mutations) for Cystic Fibrosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/repview. Accessed 15 May 2024.
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/repview. Accessed May 15, 2024.
Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/repview
Ataluren and Similar Compounds (specific Therapies for Premature Termination Codon Class I Mutations) for Cystic Fibrosis [Internet]. In: Cochrane Abstracts. [cited 2024 May 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis
ID - 434509
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434509/all/repview
DB - Evidence Central
DP - Unbound Medicine
ER -